4 completed. 3 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow 1,7-dimethylxanthine: new trials by email Literature Review of 1,7-dimethylxanthine trials Research Report on 1,7-dimethylxanthine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD L-theanine and paraxanthine, Placebo - Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD) | Not applicable | Completed | Texas Tech University Health Sciences Center | 17 | 2025-10-01 | 2026-08-24 |
| Acute Effects of Paraxanthine on Energy and Focus Paraxanthine 200mg and 300mg - Cognition, Appetite | Phase 1 / Phase 2 | Completed | Iovate Health Sciences International Inc | 25 | 2024-05-07 | 2024-10-08 |
| Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus Paraxanthine 200 mg, Paraxanthine 300 mg, Placebo - Energy, Focus | Not applicable | Completed | Iovate Health Sciences International Inc | 45 | 2023-07-18 | 2023-11-07 |
| Effects of Paraxanthine Supplementation on eSport Performancre Placebo, Paraxanthine - Cognitive Function, Gaming Performance | Not applicable | Completed | Lindenwood University | 60 | 2021-06-15 | 2026-04-16 |
Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1)
Iovate Health Sciences International Inc (2) · Lindenwood University (1) · Texas Tech University Health Sciences Center (1)
United States (4)